tm logo

Monitor this mark

View On USPTO

GLEOSTINE
Live/Registered
SECTION 8 & 15-ACCEPTED AND ACKNOWLEDGED

accepted and acknowledged

on 30 Mar 2022

Last Applicant/ Owned by

NextSource Biotechnology, LLC

80 SW 8th Street, Suite 2660

Miami

FL

33130

Serial Number

86266575 filed on 29th Apr 2014

Registration Number

4733095 registered on 05th May 2015

in the Principal Register

Correspondent Address

Thomas M Hunter

Thomas M Hunter Thomas Hunter

Somers, NY 10501

UNITED STATES

Filing Basis

1. intent to use

2. use application currently

Disclaimer

NO DATA

GLEOSTINE

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

Classification Information

Class [005]
Pharmaceutical Products

Anti-cancer preparations; Biological preparations for the treatment of cancer; Pharmaceutical products for the prevention and treatment of cancer

First Use Date in General

26th Jan 2015

First Use Date in Commerce

27th Jan 2015

Mark Details

Serial Number

No 86266575

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
05th May 2024COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
30th Mar 2022NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
30th Mar 2022REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
03rd Jan 2022TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
31st Dec 2021POST REGISTRATION ACTION MAILED - SEC. 8 & 15
18th Dec 2021CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20th Sep 2021TEAS SECTION 8 & 15 RECEIVED
14th May 2020WITHDRAWAL OF ATTORNEY GRANTED
14th May 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED
13th May 2020APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED